Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2005 | 1 |
2006 | 1 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.
Neuropsychopharmacology. 2004 Aug;29(8):1558-72. doi: 10.1038/sj.npp.1300496.
Neuropsychopharmacology. 2004.
PMID: 15173844
Clinical Trial.
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH.
D'Souza DC, et al.
Biol Psychiatry. 2005 Mar 15;57(6):594-608. doi: 10.1016/j.biopsych.2004.12.006.
Biol Psychiatry. 2005.
PMID: 15780846
Clinical Trial.
Item in Clipboard
Greater vulnerability to the amnestic effects of ketamine in males.
Morgan CJ, Perry EB, Cho HS, Krystal JH, D'Souza DC.
Morgan CJ, et al.
Psychopharmacology (Berl). 2006 Sep;187(4):405-14. doi: 10.1007/s00213-006-0409-0. Epub 2006 Aug 1.
Psychopharmacology (Berl). 2006.
PMID: 16896964
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.